Jean Brannum - Editorial Team

When it comes to mesothelioma survival rates, timing makes all the difference. Mesothelioma is a rare but aggressive can...

Synchronous pleural and peritoneal mesothelioma, two distinct forms of an aggressive mesothelioma cancer were found in a...

A new UK study challenges the standard treatment for malignant pleural mesothelioma, suggesting that chemotherapy alone...

For individuals exposed to asbestos, the looming threat of malignant pleural mesothelioma remains a serious concern. A r...

For patients diagnosed with the aggressive cancer mesothelioma, the choice of surgical treatment has always been a compl...

Sellas Life Sciences, a prominent biopharmaceutical company in the U.S. focused on late-stage clinical developments, has...

A recent study led by the University of California, Irvine (UCI) sheds light on the relationship between prolonged expos...

Asbestos, a ubiquitous building material, has long been associated with severe health risks such as mesothelioma and lun...

A groundbreaking study led by researchers at Mayo Clinic Cancer Center in Florida is revolutionizing gastric cancer trea...

In a groundbreaking discovery, researchers at Wake Forest School of Medicine have unveiled a nanoparticle therapeutic th...

Researchers at the forefront of cancer immunotherapy have unveiled a groundbreaking treatment avenue for patients battli...

In a promising breakthrough, researchers have achieved the reversal of lung fibrosis in a mouse model of idiopathic pulm...